Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics, Inc. - Common Stock (NQ:MRSN)

9.335 -0.245 (-2.56%)
Streaming Delayed Price Updated: 1:03 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,541
Open 9.540
Bid (Size) 9.160 (200)
Ask (Size) 9.320 (100)
Prev. Close 9.580
Today's Range 8.960 - 9.590
52wk Range 5.210 - 70.75
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mersana Misses Fiscal Q2 Revenue Target
Via The Motley Fool
A Look at Mersana Therapeutics's Upcoming Earnings Report
 
Via Benzinga

Performance

YTD
-73.3%
-73.3%
1 Month
+12.7%
+12.7%
3 Month
+36.1%
+36.1%
6 Month
+2.3%
+2.3%
1 Year
-79.7%
-79.7%

More News

Read More
What's going on in today's session
Via Chartmill
Thursday's session: gap up and gap down stocks
Via Chartmill
An Overview of Mersana Therapeutics's Earnings
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Preview For Mersana Therapeutics
Via Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
Via Benzinga
Earnings Scheduled For August 13, 2025
Via Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Thursday's after hours session
Via Chartmill
Earnings Scheduled For March 3, 2025
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
Earnings Scheduled For May 15, 2025
Via Benzinga
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Mersana Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mersana Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mersana Therapeutics, Inc. - Common Stock trade on?
Mersana Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mersana Therapeutics, Inc. - Common Stock?
The ticker symbol for Mersana Therapeutics, Inc. - Common Stock is MRSN on the Nasdaq Stock Market
What is the current price of Mersana Therapeutics, Inc. - Common Stock?
The current price of Mersana Therapeutics, Inc. - Common Stock is 9.335
When was Mersana Therapeutics, Inc. - Common Stock last traded?
The last trade of Mersana Therapeutics, Inc. - Common Stock was at 11/03/25 01:03 PM ET
What is the market capitalization of Mersana Therapeutics, Inc. - Common Stock?
The market capitalization of Mersana Therapeutics, Inc. - Common Stock is 669.89M
How many shares of Mersana Therapeutics, Inc. - Common Stock are outstanding?
Mersana Therapeutics, Inc. - Common Stock has 670M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.